Stay updated with breaking news from William Doyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
09.01.2023 - Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2022. Novocure is a global oncology company working to extend survival in some of the most ... Seite 1
Novocure's share price shot up 55% on Thursday after it announced results of a trial of its electric fields technology on non-small cell lung cancer patients.
The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival The full LUNAR data will be presented at a future medical
The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival The full LUNAR data will be presented at a future
Biotech investors are optimistic about the prospects for a potential treatment.